Terms: = Thyroid cancer AND TSHR, hTSHR-I, 7253, ENSG00000165409, MGC75129, LGR3 AND Treatment
75 results:
1. A Novel tshr Gene Mutation in a Family with Non-autoimmune Hyperthyroidism.
Kufoof T; Luxford C; Kannangara K; Clifton-Bligh R; Donaghue KC
Med Arch; 2024; 78(2):154-158. PubMed ID: 38566871
[TBL] [Abstract] [Full Text] [Related]
2. thyroid dysfunction caused by exposure to environmental endocrine disruptors and the underlying mechanism: A review.
He J; Xu J; Zheng M; Pan K; Yang L; Ma L; Wang C; Yu J
Chem Biol Interact; 2024 Mar; 391():110909. PubMed ID: 38340975
[TBL] [Abstract] [Full Text] [Related]
3. Establishment and Characterization of Amitrole-Induced Mouse thyroid Adenomatous Nodule-Derived Cell Lines.
Shirai YT; Hoshi N; Ward JM; Liu H; Cachau RE; Lee MP; Kimura S
Thyroid; 2024 Apr; 34(4):496-509. PubMed ID: 38149583
[No Abstract] [Full Text] [Related]
4. The effect of acromegaly on thyroid disease.
Mo C; Zhong L
Endocr J; 2023 Nov; 70(11):1051-1060. PubMed ID: 37880078
[TBL] [Abstract] [Full Text] [Related]
5. Somatostatin Receptor Type 2 and thyroid-Stimulating Hormone Receptor Expression in Oncocytic thyroid Neoplasms: Implications for Prognosis and treatment.
Gillis A; Zheng-Pywell R; McLeod C; Wang D; Ness JM; Guenter R; Whitt J; Prolla TA; Chen H; Gonzalez ML; Rose B; Lloyd RV; Jaskula-Sztul R; Lin D
Mod Pathol; 2023 Dec; 36(12):100332. PubMed ID: 37716507
[TBL] [Abstract] [Full Text] [Related]
6. Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discovery.
Yang X; Wu Y; Xu S; Li H; Peng C; Cui X; Dhoomun DK; Wang G; Xu T; Dong M; Li X; Du Y
BMC Endocr Disord; 2023 May; 23(1):113. PubMed ID: 37208644
[TBL] [Abstract] [Full Text] [Related]
7. Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations.
Whitmer D; Phay JE; Holt S; O'Donnell B; Nguyen J; Joseph D; Chi A; Wu S; Hao Y; Huang J; Klopper JP; Kloos RT; Kennedy GC; Shin J
Front Endocrinol (Lausanne); 2022; 13():1073592. PubMed ID: 36619548
[TBL] [Abstract] [Full Text] [Related]
8. Sinomenine Hydrochloride Promotes tshr-Dependent Redifferentiation in Papillary thyroid cancer.
Zhang J; Zhao A; Jia X; Li X; Liang Y; Liu Y; Xie X; Qu X; Wang Q; Zhang Y; Gao R; Yu Y; Yang A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142613
[TBL] [Abstract] [Full Text] [Related]
9. Management of Graves' hyperthyroidism: present and future.
Bartalena L; Piantanida E; Gallo D; Ippolito S; Tanda ML
Expert Rev Endocrinol Metab; 2022 Mar; 17(2):153-166. PubMed ID: 35287535
[TBL] [Abstract] [Full Text] [Related]
10. It Takes Two to Tango: IGF-I and TSH Receptors in thyroid Eye Disease.
Girnita L; Smith TJ; Janssen JAMJL
J Clin Endocrinol Metab; 2022 Aug; 107(Suppl_1):S1-S12. PubMed ID: 35167695
[TBL] [Abstract] [Full Text] [Related]
11. Long-term outcomes in corticosteroid-refractory Graves' orbitopathy treated with tocilizumab.
Moi L; Hamedani M; Ribi C
Clin Endocrinol (Oxf); 2022 Sep; 97(3):363-370. PubMed ID: 34908176
[TBL] [Abstract] [Full Text] [Related]
12. Capsaicin restores sodium iodine symporter-mediated radioiodine uptake through bypassing canonical TSH‒tshr pathway in anaplastic thyroid carcinoma cells.
Xu S; Cheng X; Wu J; Wang Y; Wang X; Wu L; Yu H; Bao J; Zhang L
J Mol Cell Biol; 2022 Jan; 13(11):791-807. PubMed ID: 34751390
[TBL] [Abstract] [Full Text] [Related]
13. Synergistic effect of metformin and vemurufenib (PLX4032) as a molecular targeted therapy in anaplastic thyroid cancer: an in vitro study.
Durai L; Ravindran S; Arvind K; Karunagaran D; Vijayalakshmi R
Mol Biol Rep; 2021 Nov; 48(11):7443-7456. PubMed ID: 34716862
[TBL] [Abstract] [Full Text] [Related]
14. Blocking the Thyrotropin Receptor with K1-70 in a Patient with Follicular thyroid cancer, Graves' Disease, and Graves' Ophthalmopathy.
Ryder M; Wentworth M; Algeciras-Schimnich A; Morris JC; Garrity J; Sanders J; Young S; Sanders P; Furmaniak J; Rees Smith B
Thyroid; 2021 Oct; 31(10):1597-1602. PubMed ID: 34114495
[No Abstract] [Full Text] [Related]
15. Hypothyroidism induces oxidative stress and DNA damage in breast.
Peixoto MS; de Vasconcelos E Souza A; Andrade IS; de Carvalho El Giusbi C; Coelho Faria C; Hecht F; Miranda-Alves L; Ferreira ACF; Carvalho DP; Fortunato RS
Endocr Relat Cancer; 2021 Jun; 28(7):505-519. PubMed ID: 34010147
[TBL] [Abstract] [Full Text] [Related]
16. Network analysis reveals essential proteins that regulate sodium-iodide symporter expression in anaplastic thyroid carcinoma.
Rakhsh-Khorshid H; Samimi H; Torabi S; Sajjadi-Jazi SM; Samadi H; Ghafouri F; Asgari Y; Haghpanah V
Sci Rep; 2020 Dec; 10(1):21440. PubMed ID: 33293661
[TBL] [Abstract] [Full Text] [Related]
17. The Molecular Function and Clinical Role of thyroid Stimulating Hormone Receptor in cancer Cells.
Chu YD; Yeh CT
Cells; 2020 Jul; 9(7):. PubMed ID: 32698392
[TBL] [Abstract] [Full Text] [Related]
18. Over expression of CDK4 and MDM2 in a patient with recurrent ALK-negative mediastinal inflammatory myofibroblastic tumor: A case report.
Hou TC; Wu PS; Huang WY; Yang YT; Tan KT; Liu SH; Chen YJ; Chen SJ; Su YW
Medicine (Baltimore); 2020 Mar; 99(12):e19577. PubMed ID: 32195970
[TBL] [Abstract] [Full Text] [Related]
19. Exosomes Expressing Thyrotropin Receptor Attenuate Autoantibody-Mediated Stimulation of Cyclic Adenosine Monophosphate Production.
Edo N; Kawakami K; Fujita Y; Morita K; Uno K; Tsukamoto K; Onose H; Ishikawa T; Ito M
Thyroid; 2019 Jul; 29(7):1012-1017. PubMed ID: 31062662
[No Abstract] [Full Text] [Related]
20. The insulin-like growth factor-I receptor and its role in thyroid-associated ophthalmopathy.
Smith TJ
Eye (Lond); 2019 Feb; 33(2):200-205. PubMed ID: 30385883
[TBL] [Abstract] [Full Text] [Related]
[Next]
